SCHEDULE: Bessemer Venture Partners Discloses Hinge Health Stake

Bessemer Venture Partners and affiliated entities have disclosed a significant beneficial ownership stake in Hinge Health, Inc., totaling 13.1% of Class A Common Stock.

Summary

• Bessemer Venture Partners X L.P. (BVP X) and Bessemer Venture Partners X Institutional L.P. (BVP X Inst), along with their general partners Deer X & Co. L.P. and Deer X & Co. Ltd., have filed a Schedule 13G.
• The filing reports beneficial ownership of Hinge Health, Inc.'s Class A Common Stock.
• Deer X & Co. L.P. and Deer X & Co. Ltd. each beneficially own 4,108,707 shares, representing 13.1% of the Class A Common Stock.
• BVP X beneficially owns 2,119,271 shares, representing 7.2% of the Class A Common Stock.
• BVP X Inst beneficially owns 1,989,436 shares, representing 6.8% of the Class A Common Stock.
• The reported shares are Class A Common Stock underlying Class B Common Stock, convertible on a 1-for-1 basis at the holder's option.
• The percentage ownership is based on a total of 27,223,448 shares of Class A Common Stock outstanding as of July 31, 2025, as reported in Hinge Health's Quarterly Report on Form 10-Q filed on August 11, 2025.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or outlook. It is a regulatory compliance document.

Future Outlook

NA

Industry Context

This filing indicates continued significant institutional investment in Hinge Health, Inc., a company operating in the digital musculoskeletal care and virtual physical therapy sector. Such disclosures are common for venture capital firms maintaining stakes in their portfolio companies post-IPO or significant funding rounds.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a prominent venture capital firm may be viewed as a sign of continued investor confidence in Hinge Health, Inc.

Key Dates

Keywords

Hinge Health, Bessemer Venture Partners, Beneficial Ownership, Schedule 13G, Class A Common Stock, Institutional Investor, Venture Capital